Principal Financial Group Inc
DUS:PG4
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
Principal Financial Group Inc
DUS:PG4
|
US |
|
N
|
NovaBay Pharmaceuticals Inc
AMEX:SDEV
|
US |
|
Reliance Sekuritas Indonesia Tbk PT
IDX:RELI
|
ID |
|
RTL Group SA
F:RRTL
|
LU |
|
A
|
Alphabet Inc
XMUN:ABEA
|
US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
US |
|
Metro AG
XETRA:B4B
|
DE |
|
Koninklijke Philips NV
F:PHI1
|
NL |
|
N
|
Naspers Ltd
JSE:NPN
|
ZA |
Wall St Price Targets
PG4 Price Targets Summary
Principal Financial Group Inc
According to Wall Street analysts, the average 1-year price target for PG4 is 80.27 EUR with a low forecast of 71.59 EUR and a high forecast of 98.93 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is PG4's stock price target?
Price Target
80.27
EUR
According to Wall Street analysts, the average 1-year price target for PG4 is 80.27 EUR with a low forecast of 71.59 EUR and a high forecast of 98.93 EUR.
What is the Revenue forecast for Principal Financial Group Inc?
Projected CAGR
6%
Over the last 14 years, the compound annual growth rate for Revenue has been 4%. The projected CAGR for the next 4 years is 6%.
What is the Net Income forecast for Principal Financial Group Inc?
Projected CAGR
24%
Over the last 14 years, the compound annual growth rate for Net Income has been 5%. The projected CAGR for the next 4 years is 24%.
